Bristol-Myers Squibb Company Financial Ratios — BMY Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	11.39	5.92	7.75	6.08	4.85	13.6	3.09	14.98	9.96	-32	30.62	25.36	29.26	-40.43	43.55
Return on Assets (%)	11.58	5.69	6.88	5.54	4.78	13.62	2.99	14.36	4.17	-7.26	6.14	6.14	8.36	-9.53	7.72
Return on Capital (%)	5.97	- -	6.65	5.23	4.14	11.44	2.69	12.43	6.24	- -	11.36	10.74	13.3	- -	12.97
Return on Invested Capital (%)	23.52	- -	11.69	6.26	6.1	15.51	3.06	20.59	4.92	- -	8.64	9.75	10.86	- -	15.61
Gross Margin (%)	73.65	73.84	71.81	75.24	76.39	74.42	71.05	71.34	69.1	72.31	78.57	78.04	76.24	71.08	71.08
EBITDA Margin (%)	34.2	26.18	22.55	13.74	12.72	25.33	20.39	25.61	23.18	29.56	41.44	41.99	39.89	32.06	36.8
Operating Margin (%)	31.24	22.31	17.89	10.79	10.45	23.36	16.59	22.79	16.5	5.15	18.4	19.72	18.21	12.19	28.48
Incremental Operating Margin (%)	39.03	74.66	80.99	240.51	2.35	97.98	-80.95	94.9	-23.07	-12.97	164.13	-250.88	78.84	-70.07	-7,463.81
Pretax Margin (%)	32.86	13.28	17.64	14.99	12.54	30.45	24.7	26.45	19.03	-16.16	17.46	16.71	18.75	-17.35	19.35
Profit Margin (%)	17.46	11.12	15.64	12.62	9.45	22.94	4.85	21.81	13.15	-21.2	15.08	13.71	17.83	-18.53	14.64
Net Income to Common Margin (%)	17.46	11.12	15.64	12.62	9.45	22.94	4.85	21.81	13.15	-21.2	15.08	13.71	17.83	-18.53	14.64
Effective Tax Rate (%)	24.65	- -	10.76	14.78	21.47	23.8	81	17.11	30.45	- -	13.39	17.74	4.74	- -	24.36
Dvd Payout Ratio (%)	33.09	75.15	88.91	116.75	145.96	55.89	273.28	52.53	76.96	-45.4	62.5	72.83	58.9	-54.53	71.49
Sustainable Growth Rate (%)	7.62	1.47	0.86	-1.02	-2.23	6	-5.36	7.11	2.29	-46.53	11.48	6.89	12.03	-62.48	12.42

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	5,491	7,394	8,340	7,832	6,689	6,708	7,962	7,349	47,538	51,673	45,596	40,717	41,464	51,200	47,139
ST Debt	115	826	359	590	139	992	987	1,703	3,479	2,504	5,117	4,400	3,281	2,227	2,463
LT Debt	5,376	6,568	7,981	7,242	6,550	5,716	6,975	5,646	44,059	49,169	40,479	36,317	38,183	48,973	44,676
Total Debt/EBITDA	0.76	1.6	2.26	3.59	3.18	1.36	1.88	1.27	7.84	4.11	2.37	2.1	2.31	3.31	2.66
Net Debt/EBITDA	-0.04	1.24	1.29	1.04	2.04	0.5	0.6	0.08	5.67	2.87	1.59	1.56	1.58	2.54	1.97
Total Debt/EBIT	0.83	1.88	2.85	4.57	3.87	1.48	2.31	1.43	11.02	23.59	5.34	4.47	5.06	8.7	3.43
Net Debt/EBIT	-0.04	1.46	1.62	1.32	2.49	0.54	0.74	0.09	7.97	16.5	3.58	3.32	3.45	6.68	2.54
EBITDA to Interest Expense	50.1	25.35	18.56	10.74	11.45	29.47	21.61	31.57	9.24	8.85	14.41	15.73	15.4	7.95	9.38
EBITDA-CapEx/Interest Expense	47.57	22.34	15.86	8.15	11.45	29.47	21.61	31.57	9.24	8.85	14.41	15.73	15.4	7.95	9.38
EBIT to Interest Expense	45.77	21.6	14.73	8.44	9.4	27.18	17.59	28.09	6.58	1.54	6.4	7.39	7.03	3.02	7.26
Interest Expense	145	182	199	203	184	167	196	183	656	1,420	1,334	1,232	1,166	1,947	1,891
Common Equity/Total Assets	100.97	91.8	85.96	97.08	100.27	100.08	93.53	98	26.75	18.21	22.06	26.64	30.54	16.42	19.09
Long-Term Debt/Equity (%)	33.88	48.16	52.38	48.33	45.41	34.97	58.88	39.97	85.22	129.8	112.42	116.71	129.5	298.83	241.41
Long-Term Debt/Capital (%)	13.89	16.27	19.19	17.78	16.93	14.07	17.68	13.53	53.47	67.07	58.02	54.56	54.1	73.69	69.42
Long-Term Debt/Total Assets (%)	16.31	18.3	20.68	21.46	20.63	16.96	20.79	16.14	33.91	41.5	37.03	37.51	40.13	52.88	49.62
Total Debt/Equity (%)	34.61	54.22	54.74	52.27	46.37	41.04	67.21	52.02	91.95	136.41	126.63	130.85	140.63	312.42	254.72
Total Debt/Capital (%)	14.19	18.32	20.05	19.23	17.29	16.52	20.18	17.61	57.69	70.49	65.35	61.17	58.75	77.04	73.24
Total Debt/Total Assets (%)	16.65	20.6	21.61	23.21	21.07	19.9	23.73	21.01	36.58	43.61	41.71	42.05	43.57	55.29	52.35
Net Debt to Equity	-1.8	42.07	31.2	15.09	29.84	15.12	21.45	3.1	66.52	95.38	84.91	97.04	96.01	239.83	188.6
Net Debt/Capital (%)	-0.87	14.82	12.51	6.43	11.86	6.79	7.47	1.26	49.08	61.49	54.8	52.57	47.89	70.05	64.45
EBITDA	7,265	4,613	3,694	2,181	2,106	4,921	4,236	5,778	6,060	12,570	19,223	19,380	17,955	15,487	17,735
EBITDA-CapEx	6,898	4,065	3,157	1,655	2,106	4,921	4,236	5,778	6,060	12,570	19,223	19,380	17,955	15,487	17,735
Operating Income (Loss)	6,637	3,932	2,931	1,714	1,730	4,539	3,447	5,141	4,314	2,190	8,537	9,104	8,195	5,887	13,724

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.12	0.34	0.36	0.88	0.53	0.72	0.71	0.82	0.84	0.86	0.79	0.42	0.55	0.46	0.46
Current Ratio	1.97	1.15	1.52	1.73	1.3	1.55	1.55	1.66	1.6	1.58	1.52	1.25	1.43	1.25	1.26
Quick Ratio	1.6	0.71	0.63	1.28	1.07	1.35	1.37	1.36	1.26	1.42	1.36	1.06	1.24	1.06	1.08
CFO/Avg Current Liab	0.67	0.86	0.34	0.3	0.26	0.36	0.57	0.7	0.57	0.75	0.79	0.6	0.63	0.66	0.6
Common Equity/Total Assets	100.97	91.8	85.96	97.08	100.27	100.08	93.53	98	26.75	18.21	22.06	26.64	30.54	16.42	19.09
Long-Term Debt/Equity (%)	33.88	48.16	52.38	48.33	45.41	34.97	58.88	39.97	85.22	129.8	112.42	116.71	129.5	298.83	241.41
Long-Term Debt/Capital (%)	13.89	16.27	19.19	17.78	16.93	14.07	17.68	13.53	53.47	67.07	58.02	54.56	54.1	73.69	69.42
Long-Term Debt/Total Assets (%)	16.31	18.3	20.68	21.46	20.63	16.96	20.79	16.14	33.91	41.5	37.03	37.51	40.13	52.88	49.62
Total Debt/Equity (%)	34.61	54.22	54.74	52.27	46.37	41.04	67.21	52.02	91.95	136.41	126.63	130.85	140.63	312.42	254.72
Total Debt/Capital (%)	14.19	18.32	20.05	19.23	17.29	16.52	20.18	17.61	57.69	70.49	65.35	61.17	58.75	77.04	73.24
Total Debt/Total Assets (%)	16.65	20.6	21.61	23.21	21.07	19.9	23.73	21.01	36.58	43.61	41.71	42.05	43.57	55.29	52.35
CFO/Total Liabilities	28.3	31.18	15.18	16.78	12.15	17.62	24.3	33.88	10.49	17.43	22.11	19.89	21.1	19.93	19.79
CFO/CapEx	13.19	12.67	6.6	5.98	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	6.16	5.47	4.99	6.11	6.93	6.8	6.01	5.94	3.18	3.13	3.74	4.41	3.63	2.93	3.46

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	18.88	8.9	9.64	8.38	6.56	5.78	5.12	5.02	4.71	6.21	6.1	5.72	5.28	5.4	5.18
Days Sales Outstanding	19.33	40.99	37.85	43.56	55.63	63.15	71.34	72.67	77.57	58.78	59.8	63.77	69.07	67.61	70.45
Inventory Turnover	4.33	3.03	2.93	2.57	2.81	4.04	5	5.48	2.94	3.7	4.77	4.57	4.28	5.35	5.31
Days Inventory Outstanding	84.37	120.39	124.66	141.93	129.84	90.42	73.04	66.63	123.99	98.7	76.54	79.83	85.35	68.19	68.71
Accounts Payable Turnover	2.52	2.03	1.87	1.58	1.76	3.09	3.04	3.14	5.15	3.7	3.52	3.47	3.5	4.04	3.92
Accounts Payable Turnover Days	144.85	179.58	194.82	230.57	207.14	118.12	120.21	116.31	70.82	98.53	103.74	105.29	104.35	90.32	93.1
Cash Conversion Cycle	-41.15	-18.21	-32.31	-45.08	-21.67	35.45	24.17	22.98	130.73	58.95	32.6	38.31	50.07	45.48	46.06
Inventory to Cash Days	-65.04	-79.39	-86.81	-98.38	-74.21	-27.28	-1.71	6.04	-46.42	-39.92	-16.75	-16.05	-16.28	-0.58	1.74
Inventories	1,384	1,657	1,498	1,560	1,221	1,241	1,166	1,195	4,293	2,074	2,095	2,339	2,662	2,557	2,690
Raw Materials	260	271	250	204	199	264	273	116	172	207	350	464	- -	- -	- -
Work In Process	646	814	757	856	868	988	931	1,152	3,267	2,015	2,111	1,850	- -	- -	- -
Finished Goods	478	572	491	500	381	310	384	356	2,227	932	543	509	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,080	-909	-484	2,662	2,557	2,690

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	59,908	54,425	87,379	97,813	114,673	97,653	100,806	84,883	109,444	140,064	134,240	153,254	106,160	114,647	109,714
- Cash & Cash Equivalents	5,776	1,656	3,586	5,571	2,385	4,237	5,421	6,911	12,346	14,546	13,979	9,123	11,464	10,346	10,209
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	-89	15	82	131	158	170	106	96	100	60	60	57	55	53	33
+ Total Debt	5,491	7,394	8,340	7,832	6,689	6,708	7,962	7,349	47,538	51,673	45,596	40,717	41,464	51,200	47,139
Enterprise Value	56,577	59,005	91,276	98,341	117,250	98,181	102,062	83,569	141,689	175,347	162,675	184,774	135,399	155,041	146,213
Total Capital	38,691	40,363	41,595	40,725	38,681	40,612	39,449	41,731	82,404	73,306	69,768	66,569	70,577	66,457	64,360
Total Debt/Capital (%)	14.19	18.32	20.05	19.23	17.29	16.52	20.18	17.61	57.69	70.49	65.35	61.17	58.75	77.04	73.24
Total Debt / EV	0.1	0.13	0.09	0.08	0.06	0.07	0.08	0.09	0.34	0.29	0.28	0.22	0.31	0.33	0.32
EV/Sales	2.66	3.35	5.57	6.19	7.08	5.05	4.91	3.7	5.42	4.12	3.51	4	3.01	3.21	3.03
EV/EBITDA	7.79	12.79	24.71	45.09	55.67	19.95	24.09	14.46	23.38	13.95	8.46	9.53	7.54	10.01	8.24
EV/EBIT	8.52	15.01	31.14	57.37	67.77	21.63	29.61	16.26	32.84	80.07	19.06	20.3	16.52	26.34	10.65
EV/Cash Flow to Firm	11.43	8.27	24.52	29.61	52.12	30.82	19.21	11.58	16.35	11.02	9.37	13.12	9.04	8.98	9.38
EV/Free Cash Flow to Firm	10.64	7.68	21.43	25.56	52.12	30.82	19.21	11.58	16.35	11.02	9.37	13.12	9.04	8.98	9.38
Diluted Market Cap	60,507	55,012	88,335	98,580	115,498	98,179	101,235	85,091	109,893	140,064	139,976	154,405	106,622	114,647	109,984
Diluted Enterprise Value	60,133	60,765	93,171	100,972	119,960	100,820	103,882	85,625	145,185	177,251	171,653	186,056	136,677	155,554	146,947
EV per Share	33.28	35.33	55.52	59.35	70.34	58.76	62.04	51.18	83.1	77.66	75.56	86.75	65.44	76.49	71.88
TTM Sales	21,244	17,621	16,385	15,879	16,560	19,427	20,776	22,561	26,145	42,518	46,385	46,159	45,006	48,300	48,195
TTM EBITDA	7,265	4,613	3,694	2,181	2,106	4,921	4,236	5,778	6,060	12,570	19,223	19,380	17,955	15,487	17,735
TTM Operating Income	6,637	3,932	2,931	1,714	1,730	4,539	3,447	5,141	4,314	2,190	8,537	9,104	8,195	5,887	13,724
TTM Cash Flow to Firm	4,949	7,136	3,723	3,321	2,249	3,185	5,312	7,218	8,666	15,911	17,362	14,079	14,971	17,266	15,586
TTM Free Cash Flow to Firm	5,316	7,684	4,260	3,847	2,249	3,185	5,312	7,218	8,666	15,911	17,362	14,079	14,971	17,266	15,586

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	11.62	7.35	21.64	26.83	54.87	32.11	19.19	12.04	13.39	9.97	8.64	11.82	7.69	7.55	7.77
EV/EBIT	8.52	15.01	31.14	57.37	67.77	21.63	29.61	16.26	32.84	80.07	19.06	20.3	16.52	26.34	10.65
Enterprise Value	56,577	59,005	91,276	98,341	117,250	98,181	102,062	83,569	141,689	175,347	162,675	184,774	135,399	155,041	146,213
Low Price	24.97	30.64	32.5	46.3	51.82	49.03	46.01	46.94	42.48	45.76	53.22	60.86	48.25	39.35	42.52
EV/Sales	2.66	3.35	5.57	6.19	7.08	5.05	4.91	3.7	5.42	4.12	3.51	4	3.01	3.21	3.03
EV/EBITDA	7.79	12.79	24.71	45.09	55.67	19.95	24.09	14.46	23.38	13.95	8.46	9.53	7.54	10.01	8.24
Price/Earnings	16.15	27.77	34.09	48.81	73.27	21.91	100.1	17.25	31.82	- -	19.19	24.22	13.23	- -	15.55
Price/Earnings Average	13.26	28.37	28.13	43.17	68.73	23.69	94.03	19.18	24.88	-15.19	19.39	24.52	16.19	-11.24	14.54
Price/Earnings High	16.24	30.96	34.95	51.07	75.49	28.91	107.98	23.25	32.1	-17.12	21.47	27.42	19.38	-13.84	18.26
Price/Earnings Low	11.44	26.11	20.85	38.28	55.2	18.38	75.16	15.58	21.06	-11.46	16.38	20.49	12.44	-8.91	12.26
Price/Book Value	1.8	1.65	2.63	2.99	3.6	2.89	3.21	2.48	3.15	6.49	5.57	5.94	3.65	7.54	6.38
Price/Book Value Average	1.48	1.69	2.17	2.64	3.38	3.13	3.02	2.75	2.46	6.35	5.62	6.01	4.47	6.62	5.97
Price/Book Value High	1.81	1.84	2.7	3.12	3.71	3.82	3.46	3.34	3.18	7.15	6.23	6.72	5.35	8.14	7.49
Price/Book Value Low	1.28	1.55	1.61	2.34	2.71	2.43	2.41	2.24	2.08	4.79	4.75	5.03	3.44	5.25	5.03
Price/Tangible Book Value	8.37	-19.61	15.01	15.77	18.73	12.08	26.71	13.06	-3.15	-3.88	-4.92	-5.81	-5.54	-3.96	-4.85
Price/Tangible Book Value Average	6.87	-20.04	12.38	13.95	17.56	13.06	25.09	14.52	-2.46	-3.79	-4.97	-5.88	-6.78	-3.47	-4.54
Price/Tangible Book Value High	8.42	-21.87	15.39	16.5	19.29	15.94	28.81	17.6	-3.18	-4.27	-5.51	-6.57	-8.11	-4.27	-5.7
Price/Tangible Book Value Low	5.93	-18.44	9.18	12.37	14.11	10.13	20.05	11.8	-2.08	-2.86	-4.2	-4.91	-5.21	-2.75	-3.83
Price/Sales	2.82	3.09	5.33	6.16	6.92	5.03	4.85	3.76	4.19	3.29	2.89	3.32	2.36	2.37	2.28
Price/Sales Average	2.32	3.16	4.4	5.45	6.5	5.44	4.56	4.18	3.27	3.22	2.92	3.36	2.89	2.08	2.13
Price/Sales High	2.84	3.44	5.47	6.45	7.13	6.63	5.23	5.07	4.22	3.63	3.24	3.76	3.46	2.56	2.67
Price/Sales Low	2	2.9	3.26	4.83	5.22	4.22	3.64	3.4	2.77	2.43	2.47	2.81	2.22	1.65	1.79
Price/Cash Flow	12.38	7.84	24.65	31.07	54.48	31.93	19.11	12.01	13.33	9.97	8.28	11.73	7.66	7.55	7.75
Price/Cash Flow Average	10.16	8.01	20.33	27.48	51.1	34.53	17.95	13.35	10.42	9.75	8.37	11.87	9.37	6.62	7.25
Price/Cash Flow High	12.45	8.74	25.27	32.51	56.12	42.14	20.61	16.19	13.45	10.98	9.27	13.28	11.22	8.15	9.1
Price/Cash Flow Low	8.77	7.37	15.07	24.37	41.04	26.79	14.35	10.85	8.82	7.35	7.07	9.92	7.2	5.25	6.11
Price/Free Cash Flow Average	9.54	7.5	17.85	23.73	51.47	34.72	18.03	13.39	10.46	9.75	8.72	11.96	9.41	6.62	7.26
Price/Free Cash Flow High	11.69	8.19	22.19	28.08	56.53	42.37	20.7	16.23	13.5	10.98	9.66	13.38	11.27	8.15	9.12
Price/Free Cash Flow Low	8.23	6.91	13.23	21.05	41.33	26.94	14.41	10.87	8.86	7.35	7.37	10	7.23	5.25	6.12
EV/Sales Average	2.3	3.48	4.69	5.6	6.76	5.57	4.68	4.21	4.62	4.1	3.61	4.05	3.55	2.93	2.9
EV/Sales High	2.82	3.77	5.76	6.6	7.4	6.77	5.36	5.09	5.57	4.5	3.92	4.44	4.12	3.41	3.44
EV/Sales Low	1.98	3.23	3.56	4.98	5.49	4.35	3.77	3.42	4.12	3.3	3.15	3.49	2.89	2.5	2.56
EV/EBITDA Average	6.72	13.3	20.82	40.76	53.19	21.99	22.98	16.42	19.94	13.85	8.7	9.64	8.91	9.14	7.87
EV/EBITDA High	8.24	14.4	25.56	48.03	58.22	26.72	26.29	19.89	24.04	15.23	9.46	10.58	10.34	10.64	9.35
EV/EBITDA Low	5.79	12.34	15.77	36.27	43.14	17.19	18.49	13.36	17.78	11.18	7.61	8.32	7.23	7.79	6.96
EV/EBIT Average	7.35	15.6	26.24	51.87	64.75	23.85	28.24	18.46	28.01	79.52	19.6	20.51	19.52	24.03	10.17
EV/EBIT High	9.02	16.9	32.21	61.11	70.87	28.97	32.31	22.35	33.77	87.44	21.3	22.53	22.65	27.98	12.08
EV/EBIT Low	6.34	14.48	19.88	46.16	52.51	18.63	22.73	15.01	24.97	64.16	17.13	17.72	15.85	20.5	9
Last Price	35.24	32.59	53.15	59.03	68.79	58.44	61.28	51.98	64.19	62.03	62.35	71.95	51.31	56.56	53.94
High Price	35.44	36.34	54.49	61.77	70.87	77.12	66.1	70.05	64.75	68.34	69.75	81.44	75.18	61.08	63.33
Enterprise Value Average	48,810	61,356	76,921	88,902	112,023	108,235	97,335	94,898	120,855	174,140	167,284	186,758	159,968	141,490	139,547
Enterprise Value High	59,874	66,441	94,418	104,745	122,602	131,509	111,381	114,926	145,691	191,499	181,849	205,118	185,602	164,716	165,776
Enterprise Value Low	42,075	56,922	58,266	79,111	90,846	84,570	78,333	77,187	107,720	140,513	146,260	161,283	129,884	120,669	123,449

Shares Outstanding	1,685	1,630	1,641	1,653	1,661	1,664	1,625	1,624	2,228	2,221	2,153	2,075	2,021	2,029	2,036
Diluted Weighted Avg Shares	1,717	1,688	1,662	1,670	1,679	1,680	1,652	1,637	1,712	2,258	2,245	2,146	2,078	2,027	2,039
Basic Weighted Avg Shares	1,700	1,670	1,644	1,657	1,667	1,671	1,645	1,633	1,705	2,258	2,153	2,130	2,069	2,027	2,034
Revenue per Share	12.5	10.55	9.97	9.58	9.93	11.63	12.63	13.82	15.33	18.83	21.54	21.67	21.75	23.83	23.69
EBITDA per Share	4.27	2.76	2.25	1.32	1.26	2.94	2.58	3.54	3.55	5.57	8.93	9.1	8.68	7.64	8.72
Operating Income per Share	3.9	2.35	1.78	1.03	1.04	2.72	2.1	3.15	2.53	0.97	3.97	4.27	3.96	2.9	6.75
Basic EPS, GAAP	2.18	1.17	1.56	1.21	0.94	2.67	0.61	3.01	2.02	-3.99	3.25	2.97	3.88	-4.41	3.47
Basic EPS from Cont Ops	3.09	1.5	1.57	1.22	0.98	2.7	0.59	3.03	2.03	-3.98	3.26	2.98	3.89	-4.41	3.47
Diluted EPS, GAAP	2.16	1.16	1.54	1.2	0.93	2.65	0.61	3.01	2.01	-3.99	3.12	2.95	3.86	-4.41	3.46
Diluted EPS from Cont Ops	3.06	1.48	1.55	1.21	0.97	2.68	0.59	3.02	2.02	-3.98	3.12	2.96	3.87	-4.41	3.46
Dividend per Share	1.33	1.37	1.4	1.45	1.49	1.52	1.57	1.6	1.57	1.8	2.04	2.18	2.29	2.4	2.48
Cash Flow per Share	2.85	4.16	2.16	1.9	1.26	1.83	3.21	4.33	4.82	6.22	7.53	6.13	6.7	7.49	6.96
Free Cash Flow per Basic Share	2.63	3.83	1.83	1.58	1.26	1.83	3.21	4.33	4.82	6.22	7.53	6.13	6.7	7.49	6.96
Cash & Equivalents per Share	5.14	1.69	2.75	4.49	2.56	3.8	4.14	5.36	9.03	7.29	8	4.34	5.94	5.36	5.25
Book Value per Share	19.58	19.73	20.18	19.77	19.1	20.19	19.08	21	20.39	9.55	11.2	12.11	14.04	7.5	8.45
Tangible Book Value per Share	4.21	-1.66	3.54	3.74	3.67	4.84	2.29	3.98	-20.39	-15.99	-12.67	-12.39	-9.26	-14.29	-11.11

Bristol-Myers Squibb Company

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)